Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
31 Cards in this Set
- Front
- Back
|
COPD stands for |
Chronic Obstructive Lung Disease |
|
|
Definition of COPD ________ and _________ lung disease Primarily caused by ______ ________ |
Preventable and treatable Primarily caused by cigarette smoking |
|
|
Definition of COPD Associated with an abnormal ________ response to noxious particles or gases Different symptoms for everyone, meaning __________ |
Inflammatory Heterogeneous |
|
|
Risk factors for COPD ________ smoke Occupational _______ and ________ Outdoor air ________ _______ and ______ Socio-economic status |
Tobacco Dusk chemicals Pollution Age and Gender |
|
|
Genetic predisposition ______ _________ antitrypsin deficiency |
Alpha one |
|
|
COPD among Adults in IL 2012 - study demonstrated that COPD is more prevalent: |
Woman Unemployed Less than high school EDLower incomeDivorced |
|
|
Indicators for COPD ________ ________ cough Chronic ________ production _______ ________ of COPD |
Dypsnea Chronic Sputum Family History |
|
|
COPD test ___________ is required |
Spirometry |
|
COPD spirometry what will be looked at? _________ _________ ________ Forced vital capacity in ______ ______ (_____)
|
Forced vital capacity One second (FEV1) FEV1/FVC |
|
COPD management Prevent _________ _________ _________ symptoms Improve _________ tolerance Prevent ________ |
Disease progression Relieve symptoms Exercise tolerance Exacerbation (flare ups) |
|
|
Gold 2017 stable COPD |
Step 1 - patient assessmentStep 2 - choose pharmalogical TherapyStep 3 - establish plan of care |
|
|
Gold standard step 1 mMRC breathlessness scale Grade _______ to ________ |
0-4 |
|
What is this scale called |
COPD assessment test |
|
|
Risk of Exacerbation Exacerbation An acute event characterized by |
Worsening of symptoms |
|
|
Step 2 __________ _________ |
Pharmalogical management |
|
Step 2 pharmalogical management 1-4 type of drugs |
Brochodilators Anticholinergic Methylxanthines Combination therapy |
|
|
Step 2 phamacological Bronchodilators work by ________ ______ muscle |
Relaxing smooth |
|
|
Anticholinergics Block ___________
|
Bronchoconstriction |
|
|
What are . . . SABA LABA SAMA LAMA |
Short/long acting bronchiodilators Short/long acting anmuscarinic |
|
|
Methylxanthines are __________ because they can be toxic |
Controversial |
|
|
Pharmalogical Anti inflammatory Inhaled ____________ Combined with ________ Can be triple therapy |
Corticosteroids LABA long acting beta agonist ICS/LABA/LAMA |
|
|
Oral Steroids _______ _________ use |
Long term |
|
|
Antibiotics used for COPD Regular is of ________ antibiotics such as |
Macrolide Azithromycin |
|
|
Gold Step 3 - _________ _______ |
Non pharmalogicologic |
|
|
Step 3 non pharmalogicologic Patient A Patient BCD |
Smoking cessation physical activity - flu vaccination pneumococcal Smoking cessation physical activity flu vaccination pneumococcal flu vaccination pneumococcal |
|
|
Step 3 Management of stable COPS ________ ________ term O2 therapy Non invasive ______ ______ vent ______ care |
Long term oxygen therapy Non invasive positive pressure ventilation Hospice care |
|
|
Exacerbation May or may not include _______ ______ Chest _____ ______ Blood work Systemic _________ ________ _______ and ______ before discharge |
Hospital admission X ray Coricosteroids Antibiotics LABA and LAMA |
|
|
Smoking Cessation Components of addiction 3 components: |
Biological Psychological Social |
|
|
Methods of quitting _________ _________ 1-800 _______ now Education Web assisted ________ intervention |
Behavior Medications - nicotine replacement therapy Quit Tobacco |
|
Never too late to stop |
Smoking |
|
|
COPD readmissions Hospitals penalized for COPD readmissions within ______ days after discharge |
30 |
